Evaluation and Management of Syncope
All patients presenting with syncope require a focused initial evaluation consisting of detailed history (including prodromal symptoms, triggers, and family history), orthostatic vital signs (supine, sitting, immediately upon standing, and at 3 minutes), cardiac examination, and 12-lead ECG—this triad identifies the cause in up to 50% of cases and guides immediate risk stratification 1.
Initial Risk Stratification
The history and physical examination should specifically assess for:
High-risk features suggesting cardiac syncope:
- Age >60 years, male sex
- Known structural heart disease, reduced ventricular function, or prior arrhythmias
- Syncope during exertion or in supine position
- Brief or absent prodrome, sudden loss of consciousness
- Palpitations preceding the event
- Family history of sudden cardiac death <50 years or inheritable conditions
- Abnormal cardiac examination findings 1
Low-risk features suggesting vasovagal syncope:
- Younger age, no cardiac disease
- Syncope only when standing
- Clear triggers: prolonged standing, emotional stress, pain, medical procedures
- Prodrome of diaphoresis, warmth, pallor, nausea
- Frequent recurrent episodes with similar characteristics 2, 1
Diagnostic Testing Strategy
ECG is mandatory in all patients 1. It may reveal diagnostic findings (bradyarrhythmias, conduction blocks, ventricular tachycardia) or suggest underlying substrates (Wolff-Parkinson-White, Brugada syndrome, long QT syndrome, hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy).
Routine cardiac biomarkers (troponin, BNP), echocardiography, and outpatient cardiac monitoring should NOT be ordered reflexively—a 2026 systematic review found substantial variability in their diagnostic accuracy (troponin LR+ 1.9-11.2, BNP LR+ 1.4-47) and concluded these tests cannot be recommended for routine use in isolation 3. However, echocardiography and outpatient monitoring show higher diagnostic yield (8%-28% and 12%-42% respectively) in patients with cardiac risk factors and may be considered in this subset 3.
Neuroimaging and routine laboratory testing have low diagnostic yield and should only be ordered when clinically indicated 4.
Disposition and Management
High-risk patients require immediate hospitalization for further evaluation if they have:
- Cardiovascular or structural heart disease
- History concerning for arrhythmia
- Abnormal ECG findings
- Severe comorbidities 4
Low-risk patients with single episodes of vasovagal syncope can be reassured and discharged after education 2, 4.
Treatment of Vasovagal Syncope
For patients with recurrent vasovagal syncope:
First-line management (Class I recommendation):
- Patient education on diagnosis and benign prognosis 2
Second-line interventions (Class IIa recommendations):
- Physical counter-pressure maneuvers (leg crossing, limb/abdominal contraction, squatting) for patients with sufficiently long prodrome—proven superior to conventional therapy alone in randomized trials 2
- Instruct patients to assume supine position when prodrome occurs 2
- Midodrine is reasonable for recurrent episodes in patients without hypertension, heart failure, or urinary retention—meta-analysis showed 43% reduction in syncope recurrence 2
Uncertain benefit (Class IIb):
- Fludrocortisone might be reasonable for inadequate response to salt/fluid intake, though pediatric RCT showed worse outcomes and adult data showed only marginally insignificant benefit; monitor potassium levels 2
- Orthostatic training (tilt-table or home wall-standing) has not shown sustained benefit in RCTs 2
Critical Pitfalls
The most common error is mistaking syncope for other causes of transient loss of consciousness (especially epileptic seizures) or failing to recognize syncope presenting as falls in older adults—this leads to inappropriate referrals, excessive testing, and increased costs 5. In older patients with unexplained falls, actively screen for syncope features including amnesia for loss of consciousness or presyncope 5.
Avoid reflexive ordering of extensive cardiac testing in clearly vasovagal syncope—this increases costs without improving outcomes 3, 4.
Driving Restrictions
Patients with vasovagal syncope can resume driving after 1 month without recurrence; those with syncope of undetermined etiology also require 1 month observation 2.